Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Rev. bras. cir. cardiovasc ; 33(6): 553-558, Nov.-Dec. 2018. tab, graf
Article Dans Anglais | LILACS | ID: biblio-977479

Résumé

Abstract Objective: The aim of this study was to compare the efficacy of two different papaverine concentrations (0.5 mg/ml and 2 mg/ml) for vasospasm prevention and their impact on endothelium integrity. Methods: We have studied distal segments of radial arteries obtained by no-touch technique from coronary artery bypass graft (CABG) patients (n=10). The vasodilatory effect of papaverine (concentrations of 0.5 mg/ml and 2 mg/ml) was assessed in vitro, in isometric tension studies using ex vivo myography (organ bath technique) and arterial rings precontracted with potassium chloride (KCl) and phenylephrine. The impact of papaverine on endothelial integrity was studied by measurement of the percentage of vessel's circumference revealing CD34 endothelial marker. Results: 2 mg/ml papaverine concentration showed stronger vasodilatatory effect than 0.5 mg/ml, but it caused significantly higher endothelial damage. Response to KCl was 7.35±3.33 mN for vessels protected with papaverine 0.5 mg/ml and 2.66±1.96 mN when papaverine in concentration of 2 mg/ml was used. The histological examination revealed a significant difference in the presence of undamaged endothelium between vessels incubated in papaverine 0.5 mg/ml (72.86±9.3%) and 2 mg/ml (50.23±13.42%), P=0.002. Conclusion: Papaverine 2 mg/ml caused the higher endothelial damage. Concentration of 0.5 mg/ml caused better preservation of the endothelial lining.


Sujets)
Humains , Mâle , Femelle , Sujet âgé , Papavérine/administration et posologie , Vasodilatateurs/administration et posologie , Maladie des artères coronaires/chirurgie , Endothélium vasculaire/effets des médicaments et des substances chimiques , Artère radiale/effets des médicaments et des substances chimiques , Spasme coronaire/prévention et contrôle , Papavérine/effets indésirables , Papavérine/pharmacologie , Vasoconstriction/effets des médicaments et des substances chimiques , Vasodilatation/effets des médicaments et des substances chimiques , Vasodilatateurs/effets indésirables , Vasodilatateurs/pharmacologie , Maladie des artères coronaires/physiopathologie , Pontage aortocoronarien/méthodes
SÉLECTION CITATIONS
Détails de la recherche